Wissenschaftliches Kolloquium
GRK2158 Scientific Colloquium
Complementary to the lecture series GRK2158 offers a scientific colloquium on current research topics in the fields of chemoresistance against microorganisms and tumors as well as immune modulation. To cover these topics external scientists will be invited to give a talk about their recent research activities.
The scientific colloquium is combined with the work-in-progress reports of the doctoral students in GRK2158.
Summer Semester 2024
The colloquia & lectures will take place in lecture hall 6H starting at 4:30 pm.
| Date & Speakers | Title |
|---|---|
| 29.04.24 | GRK Colloquium |
| Prof. Dr. John Schwabe, Structural Biology, University of Leicester | Understanding the diverse activities, functions and mechanisms of class I Histone Deacetylase (HDAC) complexes |
| 06.05.24 | GRK Colloquium |
| Dr. Kathrin Buntin, Senior Principal Scientist I Natural Product & Biomolecular Chemistry NIBR | tba |
| 13.05.24 | GRK Progress Reports |
| Lena Pollmann & Svenja Oschem | |
| 27.05.24 | GRK Progress Reports |
| Jingyu Li & Matthias Bleser | |
| 03.06.24 | GRK Progress Reports |
| Céline Davis & Adarsh Nair | |
| 10.06.24 | GRK Colloquium |
| Prof. Dr. Oliver Koch, Heisenberg-Professor of Computational Drug Discovery, Institute of Pharmaceutical and Medicinal Chemistry, University of Münster | Mycobacterial thioredoxin reductase inhibitors: A new hope for the treatment of tuberculosis? |
| 17.06.24 | GRK Progress Reports |
| Karina Krings & Alae-Eddine Moubsit | |
| 24.06.24 | GRK Colloquium |
| Prof. Dr. Oliver Krämer, Institute of Toxicology, University Medical Center Mainz | tba |
| 01.07.24 | GRK Progress Reports |
| Kira Tantsur & Christian Mammen | |
| 08.07.24 | GRK Colloquium |
| Prof. Dr. Katherine Andrews, Director Griffith Institute for Drug Discovery, Griffith University, Queensland, Australia | tba |
Winter Semester 2023/24
The colloquia will start at 4:30 pm in lecture hall 6F. Changes will be marked in bold&italic.
| Date | Speakers & Title |
|---|---|
| 23.10.23 | GRK Colloquium |
| Prof. Dr. Julia Frunzke, Forschungszentrum Juelich GmbH, Institute for Bio-and Geosciences 1, IBG-1, 52425 Juelich, Germany | Antiphage molecules produced by bacteria – a new dimension in bacterial antiviral immunity |
| 30.10.23 | GRK Lecture |
| Prof. Dr. Matthias Kassack, Pharmaceutical and Medicinal Chemistry | Chemoresistance of Cancer |
| 06.11.23 | GRK Colloquium |
| Prof. Dr. Pilar Dominguez, Chair of Excellence Labex SIGNALIFE, Head of Team 14 : Cancer Epigenetics and Immunotherapy, Mediterranean Center for Molecular Medicine, C3M, Université Cote d’Azur, Nice, France | Epigenetic activation of plasmacytoid DCs enhances anti-tumor immunity in leukemia |
| 13.11.23 | GRK Lecture |
| Prof. Dr. Thomas Kurz, Pharmaceutical and Medicinal Chemistry | The non-mevalonate biosynthesis enzyme 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) as target for the development of novel anti-infective drugs |
| 20.11.23 | GRK Colloquium |
| Prof. Dr. Andreas Reichert, Institute of Biochemistry and Molecular Medicine I, University Hospital Düsseldorf | Structure-function interplay of mitochondria or ‘How and why to get in shape?’ |
| 27.11.23 | GRK Lecture |
| Prof. Dr. Holger Stark, Pharmaceutical and Medicinal Chemistry | Drug Development from Bench to Bedside and Back to Bench |
| 04.12.23 | GRK Lecture |
| Prof. Dr. Gerhard Fritz, Toxicology | Drugs effects: Basics in Pharmacokinetics and dynamics |
| 11.12.23 | GRK Lecture |
| Prof. Dr. Jörg Pietruszka, Bioorganic Chemistry | Chemoenzymatic natural product synthesis |
| 08.01.24 | GRK Lecture |
| Prof. Dr. Thomas J. J. Müller, Organic Chemistry | Diversity Oriented Synthesis of Bioactive Compounds by One-Pot Methodologies |
| 15.01.24 | GRK Lecture |
| Prof. Dr. Holger Gohlke, Pharmaceutical and Medicinal Chemistry | Virtual Screening |
| 22.01.24 | GRK Colloquium |
| Prof. Dr. Michaela Wenzel, Chemical Biology, Chalmers University of Technology, Deputy Director of The Center for Antibiotic Resistance Research in Gothenburg (CARe), Gothenburg, Sweden | Outer membrane-selective peptides from innate bacterial proteins as new antibiotic potentiators |
| 29.01.24 | GRK Lecture |
| Prof. Dr. Sander Smits, Biochemistry I | How structural biology can help to identify resistance mechanisms |
Summer Semester 2023
The colloquia & lectures will take place in lecture hall 6D starting at 4:30 pm.
| Date / Speaker | Title | |
|---|---|---|
| 17.04.23 | GRK lecture | |
| Prof. Dr. Klaus Pfeffer, Institute of Medical Microbiology and Hospital Hygiene | Microbial pathogenesis and antimicrobial chemotherapy | |
| 24.04.23 | GRK Colloquium | |
| Dr. Gill Fisher, Griffith Institute for Drug Discovery (GRIDD), Brisbane, Australia | In vitro resistance selection and omics approaches for the identification of anti-plasmodial drug targets | |
| 08.05.23 | GRK lecture | |
| Prof. Dr. Rainer Kalscheuer, Institute of Pharmaceutical Biology and Biotechnology | Microbial pathogenesis and antimicrobial chemotherapy | |
| 15.05.23 | GRK lecture | |
| Prof. Dr. Stefanie Scheu, Institute of Medical Microbiology and Hospital Hygiene | Immune response against microorganisms and tumors | |
| 22.05.23 | GRK lecture | |
| Prof. Dr. Sebastian Wesselborg, Institute of Molecular Medicine I | Role of Apoptosis Signaling in Tumorigenesis and Therapy Resistance | |
| 05.06.23 | GRK lecture | |
| Prof. Dr. Björn Stork, Institute of Molecular Medicine I | The Role of Autophagy in Cancer: Current Concepts and Therapeutic Implications | |
| 12.06.23 | GRK lecture | |
| Dr. Dina H. El-Kashef, Institute of Pharmaceutical Biology and Biotechnology | Novel Antitumor Drug Candidates from Marine-Derived Fungi | |
| 19.06.23 | GRK lecture | |
| Dr. Sanil Bhatia, Medical Faculty, Department of Pediatric Oncology, Hematology and Clinical Immunology | Exploiting epigenetic vulnerabilities to target therapy-resistant leukemia | |
| 26.06.23 | GRK Colloquium | |
| Prof. Dr. Timm Maier, Biozentrum, University of Basel | Discovering New Target Sites by Structural Studies: Mechanisms of Inhibition of mTOR and BAM complexes. | |
| 10.07.23 | End-of-Semester Meeting |
Winter Semester 2022/23
The colloquia will start at 4:30 pm in lecture hall 5H. Changes are marked in bold&italic.
| Date | Speakers | Title |
|---|---|---|
| 17.10.22 | PhD Meeting | |
| 24.10.22 | (online, 5:30 pm) Brian Shoichet, Department of Pharmaceutical Chemistry, University of California San Francisco | Following the Rabbit into Chemical Space |
| 07.11.22 | Progress Reports | |
| Lars Seiffert | tba | |
| 14.11.22 | PI-Meeting | |
| 21.11.22 | Progress Reports | |
| Talea Knak & Stefan Höfmann | Preclinical development of 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) inhibitors | |
| 05.12.22 | Progress Reports | |
| Annabelle Friedrich | Targeting the ATG13-ATG101 interaction within the autophagy-inducing ULK1 complex for cancer therapy | |
| Korana Mudrovcic | Targeting protein-protein interactions within the autophagy-inducing ULK1 complex for cancer therapy | |
| 12.12.22 (webex) | Georg Winter, CeMM -Research Center for Molecular Medicine of the Austrian Academy of Science, Vienna | Disrupting gene control via targeted protein degradation |
| 16.01.23 | Progress Reports | |
| Moritz Klischan | Multi Component Pd-Catalysis Using ‚Chiral Acetylene’ | |
| Mariam Dubiel | tba | |
| 23.01.23 | Johanna Hölken, Institute of Pharmaceutical Biology and Biotechnology (Nicole Teusch), HHU | Engineering 3D human tissues for drug discovery: Steps towards an immune-competent skin model |
| 24.01.23 (webex) | Till Kreutzer, iRights.Law Rechtsanwälte, Berlin | Copyright and licensing of academic content and research data24 |
| 30.01.23 | Progress Reports | |
| Larissa Hinz | tba | |
| Ilka Hinxlage | tba |
Summer Semester 2022
The colloquia will take place in lecture hall 6A starting at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 25.04.22 | Prof. Dr. Nadine Ziemert, University Hospital Tübingen,Translational Natural Product Genomics | A Genome Mining Pipeline for antibiotic discovery in bacteria |
| 02.05.22 | Progress Reports | |
| Larissa Hinz | Modular synthesis of Indolophenazine-Derivatives as active agents against Toxoplasma gondii | |
| Stefan Höfmann | Development of novel 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway inhibitors | |
| 09.05.22 | Prof. Dr. Thomas Efferth, Institute of Pharmaceutical and Biomedical Sciences, Johannes-von-Gutenberg-University, Mainz | Network Pharmakologie with ABC-Transporters |
| 16.05.22 | Progress Reports | |
| Lars Seiffert | Overcoming nisin resistance – Structural variations on malonamides for lead optimization | |
| Julian Schliehe-Diecks | Characterization of novel class I/IIb HDAC inhibitors and the therapeutic potential of HDAC6 inhibition in myeloid leukemia | |
| 23.05.22 | Dr. Maximilian Barth, Institute of Pharmaceutical and Medicinal Chemistry, HHU | Drug Metabolism and Pharmacokinetics in Drug Discovery and the DMPK Service Unit at IPMC |
| 30.05.22 | Progress Reports | |
| Korana Mudrovcic | Structure-Based Lead Finding and Optimization: ULK1 and IlvB1 as Targets | |
| Annabelle Friedrich | Targeting the ATG13-ATG101 interaction within the autophagy-inducing ULK1 complex for cancer therapy | |
| 13.06.22 | Prof. Dr. Christian Ducho, Pharmazeutische und Medizinische Chemie, Saarland University | Medicinal Chemistry with Naturally Occurring Nucleoside Antibiotics |
| 20.06.22 | Progress Reports | |
| Ilka Hinxlage | Identification of novel apoptotic signaling pathways for the elimination of therapy resistant tumors | |
| 27.06.22 | Dr. Alejandro Vila, Instituto de Biología Molecular y Celular de Rosario | Inhibition of Metallo-β-lactamases inspired by snapshots of the catalytic mechanism |
| 04.07.22 | Progress Reports | |
| Mariam Dubiel | ||
| Julia Gottstein | ||
| 10.08.22 | Prof. Dr. Nobutada Tanaka, School of Pharmacy, Showa University, Tokyo, Japan | Crystal structure analyses of a key enzyme in the non- mevalonate pathway of Plasmodium falciparum |
Winter Semester 2021/2022
The colloquia will start at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 04.10.21 | Dr. Christopher Stroh, Director Translational and Biomarker Research, Merck Group | A precision medicine approach to target the receptor tyrosine kinase MET in cancer |
| 18.10.21 | Information event on the Feodor Lynen Fellowship of the Alexander von Humboldt Foundation | |
| 25.10.21 | Prof. Dr. Heike Brötz-Oesterhelt, Interfaculty Institute of Microbiology and Infection Medicine, Microbial Bioactive Compounds, University Tübingen | Antibiotic Modes of Action - Technologies & Research Stories |
| 08.11.21 | Prof. Dr. Andreas Reichert, Institute of Biochemistry and Molecular Biology I, Heinrich-Heine-University Düsseldorf | Structure-function relations of mitochondria |
| 15.11.21 | Progress Reports | |
| Julia Gottstein | Lantibiotic resistance in human pathogens | |
| Mariam Dubiel | Histamine H4 receptors in cancer - perspectives as potential molecular target | |
| 29.11.21 | Progress Reports (lecture hall 5H) | |
| Emmanuel Adeniyi | Characterization of molecular mechanisms underlying antimycobacterial activity of callyaerins | |
| Xiaoli Yang | Beauvericin exhibits immunostimulatory effects on conventional dendritic cells via activating the TLR4 signaling pathwaysistant tumors and bacterial pathogens | |
| 06.12.21 | Dr. Jan Bülle, Kutzenberger Wolff & Partner, Partner, Dipl. Chem., Patentanwalt, European Patent & Trademark Attorney | Brief Introduction to the Patent System |
| 13.12.21 | Progress Reports (lecture hall 5H) | |
| Moritz Klischan | Biaryl-based natural products as structural motif for pharmaceutically relevant compounds | |
| Lena Berning | Characterization of autophagy-modulating natural products and derivatives for the elimination of therapy-resistant tumor cells | |
| 10.01.22 | Prof. Dr. Alice McHardy, Computational Biology of Infection Research, Helmholtz Centre for Infection Research | Critical Assessment of Metagenome Interpretation - the second round of challenges |
| 17.01.22 | Progress Reports (lecture hall 5H) | |
| Marlena Sekeres | Modulation of the DNA damage response (DDR) by natural compounds (NC) to widen the therapeutic window of anticancer drugs | |
| Pablo Cea | Structure based drug design against Nisin resistance systems | |
| 24.01.22 | Prof. Dr. Robin Teufel, Pharmaceutical Biology Division, Department of Pharmaceutical Sciences, University of Basel | Insights into the biosynthesis of bioactive bacterial tropone and polyketide natural products |
| 31.01.22 | Progress Reports (via Webex) | |
| Fabian Fischer | Development of HDAC-inhibitors and HDAC-PROTACs | |
| Flaminia Mazzone | Identification and characterization of new natural products with antimicrobial activity against Toxoplasma gondii |
Summer Semester 2021
The colloquia will take place as online meetings starting at 4:30 pm. The invitation link will be send by email.
| Date | Speakers | Title |
|---|---|---|
| 19.04.21 | Progress Reports | |
| Flaminia Mazzone | Identification and characterization of new natural products with anti-microbial activity against Apicomplexa and multiresistant gram-negative rods (4MRGN) | |
| Laura Mayer | Diversity-oriented synthesis of diaryl substituted heterocycles via sequential palladium catalysis | |
| 26.04.21 | Progress Reports | |
| Pablo Cea | Structural studies of nisin resistance and immunity systems | |
| Lars Seiffert | Synthesis of small-molecule inhibitors of nisin resistance protein | |
| 10.05.21 | Progress Reports | |
| Julian Schliehe-Diecks | Characterization of synergy and resistance traits of HSP90 and HDAC inhibitors in leukemic cell lines | |
| Fabian Fischer | Development of chemosensitizing HDAC-Inhibitors and HDAC-PROTACs | |
| 17.05.21 | Dr. Christine Beemelmanns, Junior Research Group Leader Chemical Biology of Microbe-Host Interactions, Leibniz Institute for Natural Product Research and Infection Biology e.V., Hans-Knöll-Institute (HKI) | Novel Secondary Metabolites from Microbial Interactions |
| 31.05.21 | Prof. Dr. Dominic Hoepfner, Director Genomic Sciences, Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research | How to catch a target: genetic fishing expeditions with natural products |
| 07.06.21 | Progress Reports | |
| Korana Mudrovcic | Exploration of Strategies to Disrupt ULK1 Protein Complex and Chlorflavonin Optimization | |
| Annabelle Friedrich | Targeting protein-protein interactions within the autophagy-inducing ULK1 complex for cancer therapy | |
| 14.06.21 | Dr. Bert Klebl, Managing Director and Chief Scientific Officer of Lead Discovery Center GmbH, Dortmund, Germany | Pandemic Prepardness – a Pathoblocker Concept to Inhibit S. aureus Induced Infections |
| 21.06.21 | Progress Reports | |
| Talea Knak | Structural optimization of Chlorflavonin – a natural product with antimycobacterial activity | |
| Ilka Hinxlage | Identification of Novel Apoptotic Signaling Pathways for the Elimination of Therapy-Resistant Tumors | |
| 28.06.21 | Dr. Elke Röhrdanz, Head of the Unit Reproductive and Genetic Toxicology, BfArM (Federal Institute for Drugs and Medical Devices) | Non-clinical Drug Development |
| 05.07.21 | cancelled | |
| 12.07.21 | Prof. Dr. Zoe Waibler, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel | Batch testing and batch release of immunological biomedicines in Germany |
Wintersemester 2020/2021
The colloquia will take place as online meetings starting at 4:30 pm. The invitation link will be send by email.
| Date | Speakers | Title |
| 02.11.2020 | Dr. Sandra Maaß, University of Greifswald, Institute of Microbiology | Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin |
| 16.11.2020 | Prof. Dr. Maria Chiara Monti, Univerista’ degli Studi di Salerno, Italy, Pharmaceutical Department | The role of functional proteomics in disclosing natural products targets |
| 30.11.2020 | Prof. Dr. Tanja Schneider, University Bonn, Pharmaceutical Microbiology | Cell wall biosynthesis as a target for (novel) antibiotics |
| 14.12.2020 Starting 12:30 | Prof. Dr. Kui Zhu, China Agricultural University Beijing, China | The discovery of membrane targeting antibiotics |
| 18.01.2021 | Prof. Dr. Tal Dagan, Genomic Microbiology Group, Institute of Microbiology, Christian-Albrechts-University Kiel | Plasmid Darwinian fitness and its implications for antibiotic resistance evolution |
| 25.01.2021 | Prof. Dr. Daniel Hoffmann, University of Dusiburg Essen, Bioinformatics and Computational Biophysics | Statistical practice in the life sciences: tragic co |
Summer Semester 2020
The colloquia will take place as online meetings starting at 4:30 pm. The invitation link will be send by email.
| Date | Speakers | Title |
|---|---|---|
| 11.05.2020 | Kai Stühler, Institute of Molecular Medicine I, Proteome Research, Düsseldorf | Thermal Proteome Profiling and other methods |
| 22.06.2020 | Anika Christoffel, Head of In vivo Department, Pharmacelsus GmbH, Julia Przibilla, Head of In vitro Department, Pharmacelsus GmbH | Preclinical in vitro and in vivo testing |
| 06.07.2020 | Christian Hertweck, Leibniz Institute for Natural Product Research and Infection Biology / Universtity of Jena | Natural Product Biosynthesis in Underexplored Microbial Niches |
Winter Semester 2019/20
The colloquia will take place in Building 25.22. Lecture Hall 5H starting at 4:30 pm.
| Date | Speakers | Title |
| 28.10.2019 | Kick-Off Meeting | |
| 11.11.2019 | Prof. Dr. Ulrike Holzgrabe, University of Würzburg, Chair of Pharmaceutical and Medicinal Chemistry | Lead structures from nature for antiinfective drugs |
| 16.12.2019 | Prof. Dr. Hans Kreipe, Hannover Medical School, Institute of Pathology | Treating luminal breast cancer: is endocrine therapy sufficient or is additional chemotherapy needed because of endocrine resistance? |
| 13.01.2020 | Prof. Dr. Andrea Huwiler, University of Bern, Institute of Pharmacology | The contribution of sphingosine kinases and S1P to renal fibrotic processes |
| 03.02.2020 | Prof. Dr. Markus Kalesse, Leibniz University Hannover, Institute of Organic Chemistry | The synthetic road to natural products |
Summer Semester 2019
The work-in-progress seminars will take place in Building 26.41. Lecture Hall 6H starting at 4:30 pm.
| Date | Speakers |
|---|---|
| 15.04.2019 | Work-In-Progress Seminar: Haiqian Yu (RG P. Proksch), Shabnam Shaneh Sazzadeh (RG K. Pfeffer) |
| 29.04.2019 | Work-In-Progress Seminar: Chenyin Wang (RG M. Kassack), Lisa Richter (RG S. Scheu) |
| 13.05.2019 | Work-In-Progress Seminar: Yodita Asfaha (RG T. Kurz), Jana van Stuijvenberg (RG G. Fritz) |
| 17.06.2019 | Work-In-Progress Seminar: Daniel Drießen (RG T.J.J. Müller), Christian Schrenk (RG M. Kassack) |
| 01.07.2019 | Work-In-Progress Seminar: David Bickel (RG H. Gohlke), Nam Michael Tran-Cong (RG P. Proksch) |
Winter Semester 2018/2019
The scientific colloquia and the work-in-progress seminars will take place in Building 25.22. Lecture Hall 5H starting at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 15.10.2018 | Presentation of CherryKuKess - Innovative drug development for difficult-to-treat cancers (Spin-off of the department of Gynecology and Obstetrics of University Hospital Düsseldorf | |
| 22.10.2018 | Work-In-Progress Seminar: Yodita Asfaha (RG T. Kurz), Shabnam Shaneh Sazzadeh (RG K. Pfeffer) | |
| 29.10.2018 | Debriefing of Symposium 2018 | |
| 05.11.2018 | Work-In-Progress Seminar: Haiqian Yu (RG P. Proksch), Tino Seidemann (RG R. Kalscheuer) | |
| 12.11.2018 | Dr. RuAngelie Edrada-Ebel, Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK | Using Analytical Data for Metabolic-guided Producation and Isolation of Bioactive Natural Products |
| 19.11.2018 | Work-In-Progress Seminar: David Schlütermann (RG B. Stork), Christian Schrenk (RG M. Kassack) | |
| 26.11.2018 | Dr. Alexander Birkmann, Head of Research, AiCuris Anti-Infective Cures GmbH | Drug discovery in industry: Pritelivir, a non-nucleosidic inhibitor of herpes simplex virus |
| 03.12.2018 | Work-In-Progress Seminar: Hjördis Brückmann (RG H. Stark), David Bickel (RG H. Gohlke) | |
| 10.12.2018 | Dr. Dominic Hoepfner, Novartis Institutes for BioMedical Research, Chemical Biology & Therapeutics, Novartis Pharma AG | Fishing for Compound Targets using Bar-coded Deletion Collections |
| 17.12.2018 | Prof. Dr. Bin-Gui Wang, Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China | Chemical diversity of halogenated organic molecules from marine red algae |
| 07.01.2019 | Prof. Dr. Bernd Riedl, Vice President Medicinal Chemistry, Bayer AG | Chemical postevolution of natural products in the field of antibacterial therapy |
| 14.01.2019 | Work-In-Progress Seminar: Marc Pflieger (RG T. Kurz), Annika Frank (RG H. Stark), Tino Seidemann (RG T. Kurz) | |
| 21.01.2019 | Dr. Bert Klebl, Managing Director and Chief Scientific Officer of Lead Discovery Center GmbH, Dortmund, Germany | LDC – a (Proven) Model for Bridging Academia to “Pharmaceutical Industry” |
Summer Semester 2018
The scientific colloquia and the work-in-progress seminars will take place in Building 26.41. Lecture hall 6H starting at 4:30 pm.
| Date | Speakers | Title | |
|---|---|---|---|
| 16.04.2018 | Work-In-Progress Seminar: Haiqian Yu, Nam Tran-Cong, Yvonne Gröner | ||
| 07.05.2018 | Work-In-Progress Seminar: Lisa Richter, Tino Seidemann, Fabian Stuhldreier | ||
| 28.05.2018 | Prof. Dr. Andreas Kirschning, Institute of Organic Chemistry, Leibniz University Hannover | Totally Synthetic: Learning from the synthetic chemist NATURE | |
| Progress Reports: Daniel Drießen, Julia Sperlich | |||
| 04.06.2018 | PD Dr. Zoe Waibler, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel | Batch testing and batch release of immunological biomedicines in Germany | |
| 11.06.2018 | Work-In-Progress Seminar: Julian Greb, Julia Zaschke-Kriesche, Nicola Porta | ||
| 18.06.2018 | Dr. Jan Bülle, Kutzenberger Wolff & Partner, Partner, Dipl. Chem., Patentanwalt, European Patent & Trademark Attorney | Patent of drugs | |
| 02.07.2018 | Work-In-Progress Seminar: David Schlütermann, Jana Deitersen | ||
| 09.07.2018 | Prof. Dr. Werner Knöss, Federal Institute for Drugs and Medical Devices (BfArM), Head of Unit 44 Cannabis Agency, Head of Division Licensing 4, Complementary and Alternative Medicines and Traditional Medicines, Bonn, Germany | Science and Regulatory Affairs - Plant Derived Drugs | |
| 16.07.2018 | Work-In-Progress Seminar: Hjördis Brückmann, Jana van Stuijvenberg, David Bickel |
Winter Semester 2017/2018
The scientific colloquia and the work-in-progress seminars will take place in Building 25.22. Lecture Hall 5H starting at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 16.10.2017 | PD Dr. Evi Stegmann, University of Tübingen, Interfaculty Institute of Microbiology and Infection Medicine (IMIT) (invited by S. Smits) | Peptidoglycan modifications: Resistance and more? |
| Progress Reports: Julia Zaschke-Kriesche (RG Smits) | ||
| 06.11.2017 | Prof. Dr. Rebecca Wade, ZMBH Research Group Leader, University of Heidelberg (invited by H. Gohlke) | Computational Mapping of Protein Binding Sites for Drug Discovery |
| Progress Reports: Nicola Porta, David Bickel | ||
| 20.11.2017 | Prof. Dr. Verena Jendrossek, Institute of Cell biology, University of Duisburg-Essen (invited by G. Fritz) | Widening the therapeutic window: Biological approaches to optimization of radiotherapy |
| Progress Reports: Jana van Stuijvenberg, Shabnam Shaneh Sazzadeh | ||
| 04.12.2017 | Prof. Dr. Michael Gütschow, University of Bonn | Cathepsin Inhibitors: From Peptides to Potential Cancer Therapeutics and Diagnostics |
| Progress Reports: Annika Frank, Hjördis Brückmann | ||
| 18.12.2017 | Prof. Dr. Wolfgang A. Schulz, Clinical Research Lab for Urology, University Medical Centre Düsseldorf | Introduction to Cancer Epigenetics |
| Progress Reports: Christian Schrenk, Chenyin Wang | ||
| 22.01.2018 | Jun.-Prof. Dr. Finn Hansen, Institute of Pharmacy, University of Leipzig | Rational design and diversity-oriented synthesis of selective histone deacetylase (HDAC) inhibitors for the epigenetic therapy of cancer |
| Progress Reports: Yodita Asfaha, Marc Pflieger |
Summer Semester 2017
The scientific colloquia and the work-in-progress seminars will take place in
Building 26.41. Level U1/00 Lecture hall 6H starting at 4:00 pm.
The scientific colloquium on June 12th will start at 4:30 pm.
| Date | Speakers | Title |
|---|---|---|
| 08.05.2017 | Prof. Dr. Nicole Teusch, TH Köln, Faculty of Applied Natural Sciences (invited by P. Proksch) | Indolactam V analogs as inhibitors of proteinase activated receptor (PAR)2 in triple negative breast cancer |
| Progress Reports: Mariam Moussa, Nam Tran-Cong, Haiqian Yu | ||
| 22.05.2017 | Prof. Dr. Julia Bandow, Ruhr-University Bochum, Chair of Microbial Biology/ Group of Microbial Antibiotics Research (invited by R. Kalscheuer) | Antibacterial Strategies |
| Progress Reports: Yvonne Gröner, Tino Seidemann | ||
| 12.06.2017 4:30 pm | Prof. Dr. Hans Reinke, Leibniz Research Institute for Environmental Medicine, Reinke research group: chronobiology and environmental medicine (invited by B. Stork) | Crosstalk of Clock Gene Expression and Autophagy in Aging |
| Progress Reports: Jana Deitersen, David Schlütermann | ||
| 26.06.2017 | Dr. Justine Rudner, Institute of Cell Biology, University of Duisburg-Essen (invited by S. Wesselborg) | New strategies to improve radiation therapy |
| Progress Reports: Fabian Stuhldreier, Philip Böhler | ||
| 10.07.2017 | Prof. Dr. Andreas Reichert, Institute of Biochemistry and Molecular Biology I, University Hospital Düsseldorf | Mitochondrial quality control – how to sort out and dispose dysfunctional mitochondria |
| Progress Reports: Anja Weber, Julian Greb | ||
| 24.07.2017 | Dr. Hubertus Hochrein, Bavarian Nordic, München (invited by Stefanie Scheu) | Fighting Infectious Diseases and Cancer with Poxviruses |
| Progress Reports: Lisa Richter, Daniel Drießen |